Biomarker framework for chronic airway diseases. Positioning ADAM17 across immune cells in COPD and asthma
Chronic obstructive pulmonary disease (COPD) and asthma are heterogeneous respiratory diseases with overlapping symptoms but distinct underlying biology. As both diseases involve dysregulated inflammatory signalling, identifying disease- and compartment-specific pathways and biomarkers could improve diagnosis and treatment. A disintegrin and metalloproteinase 17 (ADAM17) is a key sheddase that inf
